PLEASE NOTE: THIS RESOLUTION WILL BE DEBATED AT THE 2015 COUNCIL MEETING. RESOLUTIONS ARE NOT OFFICIAL UNTIL ADOPTED BY THE COUNCIL AND THE BOARD OF DIRECTORS (AS APPLICABLE). RESOLUTION: 16(15) SUBMITTED BY: Larry Bedard, MD, FACEP Jerome Hoffman, MD, FACEP Dan Morhaim, MD, FACEP SUBJECT: Decriminalization and Legalization of Marijuana PURPOSE: Directs ACEP to support decriminalization for possession of marijuana for recreational use by adults and to support state and federal governments to legalize, regulate, and tax marijuana for adult use. FISCAL IMPACT: Budgeted committee and staff resources for developing a policy statement and supporting legislative and regulatory efforts. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 WHEREAS, The prohibition of marijuana is almost universally accepted as a failed public health and criminal justice policy; and WHEREAS, The United States, with 5% of the world’s population, incarcerates 25% of the world’s criminals, making the U.S. exceptional by having the highest per-capita incarceration rate in the world; and WHEREAS, More than 600,000 thousand people a year are arrested, prosecuted, and incarcerated for the possession of a small amount of marijuana for personal use; and WHEREAS, The single biggest segment of the prison population is incarcerated for the possession and use of drugs and violation of parole by testing positive for marijuana use; and WHEREAS, The prohibition of marijuana is an unjust, racist policy because it results in significant racial disparities as 3-4 times as many Afro-Americans and Latinos as whites are arrested, prosecuted, and incarcerated for identical infractions; and WHEREAS, Decriminalization of marijuana use would protect people from the wide-ranging and debilitating consequences and stigma of a criminal conviction, in areas such as employment, housing, education, veteran benefits, and parental rights; and WHEREAS, Emergency Physicians, nurses, and other personnel are forced to participate in this failed, unjust system by being required to provide medical evaluation of adolescents for incarceration in juvenile facilities; and WHEREAS, Decriminalization of marijuana would reduce criminal justice costs and allow law enforcement resources to be directed to prevent and prosecute serious and violent crimes; and WHEREAS, The following 16 states have decriminalized possession of small amounts of marijuana: California, Connecticut, Delaware, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New York, North Carolina, Ohio, Rhode Island, and Vermont; and WHEREAS, Colorado, Washington, Oregon, and Alaska have legalized the possession of marijuana for adult recreational use without significant adverse effects; and Resolution 16(15) Decriminalization and Legalization of Marijuana Page 2 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 WHEREAS, More than 50% of the U.S. population now lives in states that have approved cannabis for medical use; and WHEREAS, A recent Gallup poll showed 58% of American support the legalization of marijuana for recreational use; and WHEREAS, Economists estimate that the underground marijuana market to be valued at between $70 billion and $120 billion, almost exclusively in cash; and WHEREAS, Tax revenue from a legalized and regulated marijuana industry would result in billions of dollars collected, which could be used for education, addiction treatment, and health care access; and WHEREAS, There is no record in history of any person ever dying from a marijuana overdose, though hundreds of thousands have died from the legal drugs alcohol and tobacco; and WHEREAS, The AMA’s Code of Ethics states: “In general if a physician believes a law is unjust they should work to change it”; therefore be it RESOLVED, That ACEP believes that the federal and state governments should decriminalize the possession of small amounts of marijuana for personal use for people aged 21 and older; and be it further RESOLVED, That ACEP believes that state and the federal government should legalize, regulate, and tax marijuana for adult use. Background This resolution calls for ACEP to support decriminalization for possession of small amounts of marijuana for personal use for people aged 21 and older and support legalization, regulation, and taxation of marijuana for adult use. This resolution is similar to previously submitted resolutions (see prior Council action). Two of the states that have legalized marijuana, CO and WA, now have at least a year of post implementation experience. Colorado The state has collected more than $76 million in taxes and allocated more than $8 million in retail tax revenue for youth substance abuse prevention and education, mental health, and community-based developmental programs. In addition to the $2.5 million allocated to fund health workers in Colorado schools, $2 million of marijuana tax revenue has been allocated to help fund community-based youth services programs that offer mentoring and focus on drug prevention and school retention, and more than $4.3 million will fund school-based outreach programs for students using marijuana. In addition, arrests for marijuana possession are down 84%. Washington State Washington has seen $83 million in tax revenue from sales and has used some of these funds for substance abuse programs, community health services, prevention and treatment, and research on marijuana. Arrests for possession are down 98%, violent crime has decreased slightly in the state, and there has been no increase in traffic fatalities. Oregon and Alaska are in earlier stages of implementation. While total decriminalization for recreational use by adults has not been embraced widely by the states, clearly opinions are changing across the country with regard to medical use of marijuana. Most of the states that have passed new laws allowing medical marijuana use have done so in very limited ways. Interestingly, many of the new laws are named for individuals suffering from various medical conditions that sought pain or symptom relief Resolution 16(15) Decriminalization and Legalization of Marijuana Page 3 through use of some form of cannabis and appealed to their legislators. Since the 2014 Council resolution, a few more states have passed laws approving the use of medical marijuana, although most of these are strictly limited. Legal Medical Marijuana States Alaska Arizona California Colorado Connecticut Delaware Georgia Hawaii Illinois Maine Maryland Massachusetts Michigan Minnesota 1998 2010 1996 2000 2012 2011 2015 2000 2013 1999 2014 2012 2008 2014 Montana Nevada New Hampshire New Jersey New Mexico New York Oklahoma Oregon Rhode Island Texas Vermont Virginia Washington Washington, DC 2004 2000 2013 2010 2007 2014 2015 1998 2006 2015 2004 2015 2008 2010 It is not clear if a national consensus has been reached on research reflecting potential benefits of medical marijuana, but, in addition to the table above, several other states have approved tightly controlled use of medical marijuana for specific conditions (primarily epilepsy and MS): AL, FL, IA, KY, MS, NC, SC, TN, UT, and WI. In 2014 or 2015, legislation to permit medical marijuana in ID was vetoed by the governor, and legislation failed to pass in KS. The level of legislative activity on the part of over half the states calls into question the justification of the Drug Enforcement Agency’s (DEA) continuing position “that marijuana has no known medical benefits.” While the DEA refers to smoked cannabis specifically, the Schedule I categorization has continued to baffle clinicians and researchers alike. This categorization also stands in stark relief to lesser classification of opioids – drugs that have caused a national crisis of overdose deaths. A 2015 study published by the National Bureau of Economic Research, (a non-partisan think-tank), "States permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not." In 2014, the Journal of the American Medical Association (JAMA) Internal Medicine also reported that the enactment of statewide medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates. "States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws," researchers concluded. Specifically, they determined that overdose deaths from opioids decreased by an average of 20 percent one year after the law's implementation, 25 percent by two years, and up to 33 percent by years five and six. Since 2008, the American College of Physicians has publically supported research into the therapeutic role of marijuana. Changes in state law do not change the fact that using marijuana continues to be an offense under the Federal Controlled Substances Act and that federal law can pre-empt state law on this issue. In 2011, the DEA denied a petition to reschedule marijuana, and in 2013 a three-judge panel of the US Court of Appeals for DC argued that judicial review of federal status (i.e., Schedule I) was not warranted. In the states that allow the use of medical marijuana, physicians are generally not allowed to “prescribe” it; they may only “recommend” its use or “advise consideration” of such therapy. A 2015 Pew Research Center opinion poll found that the proportion of adults supporting legalization – at least for medical use, is now over 50 percent, compared to 16 percent in 1990. In spite of the seeming success of legalization in CO, some sheriffs from the State, as well as from NE and KS have filed lawsuits claiming that the CO law is unconstitutional and imposes a burden on law enforcement. Resolution 16(15) Decriminalization and Legalization of Marijuana Page 4 ACEP Strategic Plan Reference Promote quality and patient safety, including development and validation of quality measures. Fiscal Impact Budgeted committee and staff resources for developing a policy statement and supporting legislative and regulatory efforts. Prior Council Action Resolution 27(14) National Decriminalization of Possession of Marijuana for Personal and Medical Use not adopted. Amended Resolution 19 (14) Cannabis Recommendations by Emergency Physicians not adopted. The original resolution called for ACEP to support emergency physician rights to recommend medical marijuana where it is legal; object to any punishment or denial of rights and privileges at the state or federal level for emergency physicians who recommend medical marijuana; and support research for medical uses, risks and benefits of marijuana. The amended resolution directed ACEP to support research into the medical uses, risks, and benefits of marijuana. Resolution 23 (13) Legalization and Taxation of Marijuana for both Adult and Medicinal Use not adopted. This resolution requested ACEP to support, endorse, and advocate for the legalization and taxation of marijuana. Resolution 25 (11) Regulate Marijuana Like Tobacco not adopted. This resolution would have revised ACEP policy on tobacco products to apply to marijuana or cannabis. Resolution 20(10) Legalization and Taxation of Marijuana not adopted. This resolution requested ACEP to support, endorse, and advocate for the legalization and taxation of marijuana. Resolution 16 (10) Classification Schedule of Marijuana as a Controlled Substance not adopted. The resolution requested ACEP to convene a Marijuana Technical Advisory Committee to advocate for change in the classification status of marijuana from a DEA Schedule I to a Schedule II drug. Resolution 16(09) Legalization and Taxation of Marijuana not adopted. This resolution requested ACEP to support, endorse, and advocate for the legalization and taxation of marijuana and for a trust fund to be established using tax revenue from marijuana sales that would fund research and treatment of drugs and alcohol dependence. Prior Board Action None Background Information Prepared by: Barbara Tomar Federal Affairs Director Reviewed By: Kevin Klauer, DO, EJD, FACEP, Speaker James Cusick, MD, FACEP, Vice Speaker Dean Wilkerson, JD, MBA, CAE, Council Secretary and Executive Director